13035-61-5 - Factory, Suppliers, Manufacturers from China

13035-61-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

β-D-Ribofuranose 1,2,3,5-Tetraacetate CAS 13035-61-5 Assay 98.0%~102.0% (UV) High Purity
Read More

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Related Blog
Reviews

New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...

2022.05.15 18:16:03
2022.05.13 22:47:01
2022.03.18 08:02:56
2022.01.29 14:01:11
2021.11.21 11:08:39
2021.11.17 05:40:59

13035-61-5 - Factory, Suppliers, Manufacturers from China

Related Products

β-D-Ribofuranose 1,2,3,5-Tetraacetate CAS 13035-61-5 Assay 98.0%~102.0% (UV) High Purity

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

N,N-Dimethylethylenediamine CAS 108-00-9 Purity >99.0% (GC)

Ac-Arg-OH.2H2O CAS 155-84-0 N-α-Acetyl-L-Arginine Dihydrate Purity >98.0% (HPLC)

Boc-D-Homoserine Lactone CAS 67198-86-1 Purity >99.0% (HPLC)

2-Chloro-3-(Trifluoromethyl)pyridine CAS 65753-47-1 Purity >98.0% (GC) Factory

5-Bromo-2-Iodopyridine CAS 223463-13-6 Assay >98.0% (GC) Factory High Quality

3'-Chloroacetophenone CAS 99-02-5 Purity >99.0% (GC)

4'-Chlorovalerophenone CAS 25017-08-7 Purity >98.0% (GC)

4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS 327-78-6 Purity ≥99.0% Sorafenib Tosylate Intermediate Factory

Indole-7-Carboxaldehyde CAS 1074-88-0 Purity >99.0% (HPLC) Factory High Quality

Trichloroisocyanuric Acid (TCCA) CAS 87-90-1 Purity >97.0% (Titration)

2,2,6,6-Tetramethylpiperidine CAS 768-66-1 Purity >99.0% (GC) (T)

4-Quinolinecarboxaldehyde CAS 4363-93-3 Purity >97.0% (GC)(T)

New COVID treatments offer hope

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

Xi presents award to top scientists

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

2022.05.15 18:16:03

2022.05.13 22:47:01

2022.03.18 08:02:56

2022.01.29 14:01:11

2021.11.21 11:08:39

2021.11.17 05:40:59

related search